发明名称 GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKE
摘要 The invention relates to procedure and methods of determining a susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter and Stroke, by assessing the presence or absence of alleles at polymorphic markers found to be associated with Atrial Fibrillation, Atrial Flutter and Stroke. The invention further relates to kits encompassing reagents for assessing such markers, and diagnostic methods, uses and procedures for utilizing such susceptibility markers.
申请公布号 US2014227693(A1) 申请公布日期 2014.08.14
申请号 US201414153926 申请日期 2014.01.13
申请人 deCODE Genetics ehf. 发明人 Helgadottir Anna;Gudbjartsson Daniel
分类号 C12Q1/68;G06F19/18 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method of determining a susceptibility to cardiac arrhythmia or stroke in a human individual, the method comprising determining the presence or absence of at least one allele of at least one polymorphic marker in a nucleic acid sample from the individual, wherein the at least one polymorphic marker is selected from the polymorphic markers set forth in Table 5, and markers in linkage disequilibrium therewith, and wherein determination of the presence or absence of the at least one allele is indicative of a susceptibility to cardiac arrhythmia or stroke in the individual.
地址 Reykjavik IS